CHARM Therapeutics
Biotechnology Research in United Kingdom
Overview
CHARM's lead program is a next-generation menin inhibitor for the treatment of acute myeloid leukemia (AML). Unlike first-generation menin inhibitors that rapidly lose potency due to menin resistance mutations, CHARM's candidates are specifically designed to maintain potency against all known clinical resistance mutations, potentially delivering the durable responses that patients desperately need.
Tagline
Protein-ligand intelligence to deliver next generation small molecule therapeutics
EMPLOYEES
11-50 employees
FOUNDED
2021
HQ
London
TYPE
Privately Held
Location
- Street
- —
- City
- London
- Region
- —
- Postal code
- —
- Country
- United Kingdom
Email patterns
See email patterns for CHARM Therapeutics
Address formats, how often each is used and the mail provider.
Start for freeTrade fairs
FAQ
What is the company name?
charmtx.com is the website of CHARM Therapeutics.
What is the industry of the company?
CHARM Therapeutics (charmtx.com) is in the Biotechnology Research industry.
When was the company founded?
CHARM Therapeutics (charmtx.com) was founded in 2021.
How many employees does the company have?
CHARM Therapeutics (charmtx.com) has 11-50 employees.
What is the company type?
The company type of CHARM Therapeutics (charmtx.com) is Privately Held.
Where is the company headquartered?
CHARM Therapeutics (charmtx.com) is headquartered in London.
What is the address of the company?
The address of CHARM Therapeutics (charmtx.com) is London, United Kingdom.
What are the social media accounts of the company?
The social media account of CHARM Therapeutics (charmtx.com) is LinkedIn.
Social media